Pediatric Safety

The goal of this clinical trial is to evaluate the dermatological safety and acceptability of a cosmetic product in healthy pediatric participants. The main questions it aims to answer are: * Does the investigational product demonstrate pediatric acceptability under normal conditions of use? * Does the investigational product present a low risk of skin irritation in the pediatric population? * Are any discomfort sensations reported during product use? Participants will: * Apply the investigational product to the face and body twice daily for 21 days. * Undergo clinical evaluations to assess skin tolerability and identify any signs of irritation or adverse reactions. * Be monitored for potential discomfort sensations throughout the study period. The study will enroll 33 healthy male and female participants aged from 7 days to 14 years. This is a single-center, single-blind clinical trial designed to evaluate the safety of the investigational product through clinical assessments under normal conditions of use.